MICHELE LAINE: Open Payments
NPI 1457328742 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,824 in 16 payments from 10 companies in 2025. Trend: 2023 $13,496 · 2024 $8,787 · 2025 $4,824
Speaker / faculty: $2,304Food & beverage: $1,428Speaker / faculty: $1,092
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $2,568 |
| Dexcom, Inc. | 4 | $1,224 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $253 |
| Sequel Med Tech, LLC | 1 | $178 |
| Xeris Pharmaceuticals, Inc. | 1 | $129 |
| Tandem Diabetes Care, Inc. | 1 | $126 |
| Ascendis Pharma Endocrinology Inc | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $54 |
| Lilly USA, LLC | 1 | $49 |
Products named: TZIELD, DEXCOM G7 GSS (161), Kerendia, TWIIST, Dexcom G6 Transmitter, RECORLEV, t:slim X2 Insulin Pump with Control-IQ, Yorvipath.
Industry payments across FL — which companies pay providers there.
